Storia in 3 fonti

First Oral Carbapenem Approved for Complicated UTIs

Tebipenem pivoxil proved noninferior to IV imipenem-cilastatin in hospitalized patients

Raccontata da

healio.com

medpagetoday.com

benzinga.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo1 g fa

First Oral Carbapenem Approved for Complicated UTIs

Tebipenem pivoxil proved noninferior to IV imipenem-cilastatin in hospitalized patients

originale

healio.com1 g fa

FDA approves oral Utebzi for complicated UTIs

The FDA has approved oral Utebzi tablets as a treatment for complicated urinary tract infections, including pyelonephritis, in adults with “limited or no alternative oral treatment options,” the agency announced.Utebzi…

Leggi questa versione → originale

benzinga.com23 h fa

GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs - GSK (NYSE:GSK), S

FDA approves GSK and SPRO's Utebzi, the first oral carbapenem for cUTIs. Launch planned for late 2026. See market reaction.

Leggi questa versione → originale

Timeline cronologica

mercoledì 17 giugno 2026·healio.com
FDA approves oral Utebzi for complicated UTIs
The FDA has approved oral Utebzi tablets as a treatment for complicated urinary tract infections, including pyelonephritis, in adults with “limited or no alternative oral…
mercoledì 17 giugno 2026·medpagetoday.com
First Oral Carbapenem Approved for Complicated UTIs
Tebipenem pivoxil proved noninferior to IV imipenem-cilastatin in hospitalized patients
mercoledì 17 giugno 2026·benzinga.com
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs - GSK (NYSE:GSK), S
FDA approves GSK and SPRO's Utebzi, the first oral carbapenem for cUTIs. Launch planned for late 2026. See market reaction.